Finance

Lists
Why is 6541 down 2.14%?
Dive Deeper
6541:TPE
Tanvex Biopharma Inc
NT$27.50
-2.14%
(-0.60) 1D
Nov 16, 1:30:33 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6541...
Open
NT$28.50
High
NT$28.50
Low
NT$27.25
Mkt. cap
7.29B
Avg. vol.
458.98K
Volume
378.23K
52-wk high
NT$65.50
52-wk low
NT$24.30
EPS
-NT$5.56
Shares outstanding
242.67M
No. of employees
215
Open
NT$28.50
High
NT$28.50
Low
NT$27.25
Mkt. cap
7.29B
Avg. vol.
458.98K
Volume
378.23K
52-wk high
NT$65.50
52-wk low
NT$24.30
EPS
-NT$5.56
Shares outstanding
242.67M
No. of employees
215
News stories
From web sources and news partners
About Tanvex Biopharma Inc
CEO-
Employees215
Founded2011
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitetanvex.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
178.95M
132.83M
220.44M
158.84M
Cost of goods sold
422.66M
399.36M
446.37M
399.62M
Cost of revenue
422.66M
399.36M
446.37M
399.62M
Research and development expenses
13.26M
24.24M
19.86M
10.67M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
104.26M
108.51M
121.17M
108.24M
Operating expense
129.86M
133.70M
141.15M
118.94M
Total operating expenses
552.52M
533.06M
587.52M
518.56M
Operating income
-373.57M
-400.23M
-367.07M
-359.72M
Other non operating income
44.99M
188.00K
418.00K
-30.58M
EBT including unusual items
-420.53M
-388.70M
-382.53M
-405.98M
EBT excluding unusual items
-305.62M
-388.70M
-382.53M
-405.98M
Income tax expense
3.00K
27.00K
1.00K
-5.84M
Effective tax rate
-
-0.01%
-
1.44%
Other operating expenses
-
-
-
25.00K
Net income
-420.54M
-388.72M
-382.53M
-400.14M
Net profit margin
-235.00%
-292.65%
-173.53%
-251.92%
Earnings per share
-
-
-
-
Interest and investment income
11.66M
6.03M
5.01M
5.72M
Interest expense
-11.31M
-11.70M
-16.53M
-21.40M
Net interest expenses
354.00K
-5.67M
-11.52M
-15.68M
Depreciation and amortization charges
-
-
-
-
EBITDA
-370.64M
-357.68M
-326.85M
-164.28M
Gain or loss from assets sale
62.12M
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps